The ventral tegmental area (VTA) and in particular VTA dopamine (DA) neurons are postulated to play a central role in reward, motivation and drug addiction. However, most evidence implicating VTA DA neurons in these functions is based on indirect electrophysiological characterization, rather than cytochemical identification. These physiological criteria were first established in the substantia nigra pars compacta (SNc), but their validity in the VTA is uncertain. In the current study we found that while 88 ± 2% of SNc neurons labelled by the neuronal marker NeuN were co-labelled for the catecholamine enzyme tyrosine hydroxylase (TH), a much smaller percentage (55 ± 2%) of VTA neurons co-expressed TH. In addition, using in vitro whole-cell recordings we found that widely accepted physiological criteria for VTA DA neurons, including the hyperpolarization-activated inwardly rectifying non-specific cation current (I h ), spike duration, and inhibition by DA D2 receptor agonists, do not reliably predict the DA content of VTA neurons. We could not distinguish DA neurons from other VTA neurons by size, shape, input resistance, I h size, or spontaneous firing rate. Although the absence of an I h reliably predicted that a VTA neuron was non-dopaminergic, and I h (−) neurons differ from I h (+) neurons in firing rate, interspike interval (ISI) standard deviation, and ISI skew, no physiological property examined here is both sensitive and selective for DA neurons in the VTA. We conclude that reliable physiological criteria for VTA DA neuron identification have yet to be determined, and that the criteria currently being used are unreliable. Ventral tegmental area (VTA) neurons are the source of dopamine (DA) projections to the limbic forebrain and have been implicated in attention, memory, reward and motivation (Chudasama & Robbins, 2004;Wise, 2004;Nicola et al. 2005). In vivo single unit electrophysiological recordings have demonstrated that VTA neurons respond to novel stimuli, unexpected rewards, and reward predictive sensory cues, and that they fire in a pattern consistent with the encoding of reward expectancy error (Schultz, 1998;Hyland et al. 2002;Dommett et al. 2005). The conclusion that neurons with these patterns of response are dopaminergic is critical to hypotheses about the role of dopamine signalling in motivation, reward and drug addiction.Unfortunately, current criteria for VTA DA neuron identification are based largely on indirect and in some cases conflicting evidence. Furthermore, when these criteria are used, subsets of putative DA neurons have different patterns of response (e.g. Kiyatkin & Rebec, 2001;Hyland et al. 2002;Tobler et al. 2003). For example, in vivo studies in which DA neurons were identified during extracellular recordings by action potential waveform and firing pattern properties found both excitations and inhibitions induced by noxious stimuli (Mantz et al. 1989;Romo & Schultz, 1989). However, Ungless et al. (2004), using in vivo intracellular recordings, showed that only inhibitions occ...
Dopaminergic afferents arising from the ventral tegmental area (VTA) are crucial elements in the neural circuits that mediate arousal, motivation, and reinforcement. Two major targets of these afferents are the medial prefrontal cortex (mPFC) and the nucleus accumbens (NAc). Whereas dopamine (DA) in the mPFC has been implicated in working memory and attentional processes, DA in the NAc is required for responding to reward predictive cues. These distinct functions suggest a role for independent firing patterns of dopaminergic neurons projecting to these brain regions. In fact, DA release in mPFC and NAc can be differentially modulated. However, to date, electrophysiological studies have largely overlooked heterogeneity among VTA neurons. Here, we provide direct evidence for differential neurotransmitter control of DA neural activity and corresponding DA release based on projection target. opioid receptor agonists inhibit VTA DA neurons that project to the mPFC but not those that project to the NAc. Moreover, DA levels in the mPFC, but not the NAc, are reduced after local infusion of opioid receptor agonists into the VTA. These findings demonstrate that DA release in specific brain regions can be independently regulated by opioid targeting of a subpopulation of VTA DA neurons. Selective control of VTA DA neurons projecting to the mPFC has important implications for understanding addiction, attention disorders, and schizophrenia, all of which are associated with DA dysfunction in the mPFC.GABA ͉ reward ͉ motivation ͉ nucleus accumbens ͉ ventral tegmental area T he dopaminergic neurons of the ventral tegmental area (VTA) play a critical role in motivation and reinforcement (1-3). Two major projection targets of VTA dopamine (DA) neurons are the medial prefrontal cortex (mPFC) and the nucleus accumbens (NAc). DA plays different roles in these two projection targets, contributing to working memory processes in the mPFC (4, 5) and motivated responding in the NAc (6). Despite evidence that DA levels in the mPFC and NAc are differentially modulated during various behavioral conditions (7,8), electrophysiological studies have focused on the functional similarities among the VTA neurons.The VTA is an important site for opioid control of goaldirected behaviors (9). We previously showed that opioid receptor (KOP-R) agonists directly inhibit a subset of DA neurons in the VTA through activation of a G-protein-coupled, inwardly rectifying potassium channel (10). This finding, in conjunction with previous reports that limbic and cortical projections arise from largely separate populations of VTA neurons (11, 12), led us to hypothesize that postsynaptic KOP-R agonist effects on VTA neurons segregate on the basis of projection target. To address this question, we made whole-cell, patchclamp recordings in VTA neurons that were retrogradely labeled from the NAc or the mPFC and tested their postsynaptic sensitivity to KOP-R agonists. Neurons were filled with biocytin, and, after recording, brain slices were fixed and immunohistochemi...
The ventral tegmental area (VTA) is a heterogeneous midbrain structure that contains dopamine (DA), GABA, and glutamate neurons that project to many different brain regions. Here, we combined retrograde tracing with immunocytochemistry against tyrosine hydroxylase (TH) or glutamate decarboxylase (GAD) to systematically compare the proportion of dopaminergic and GABAergic VTA projections to 10 target nuclei: anterior cingulate, prelimbic, and infralimbic cortex; nucleus accumbens core, medial shell, and lateral shell; anterior and posterior basolateral amygdala; ventral pallidum; and periaqueductal gray. Overall, the non-dopaminergic component predominated VTA efferents, accounting for more than 50% of all projecting neurons to each region except the nucleus accumbens core. In addition, GABA neurons contributed no more than 20% to each projection, with the exception of the projection to the ventrolateral periaqueductal gray, where the GABAergic contribution approached 50%. Therefore, there is likely a significant glutamatergic component to many of the VTA's projections. We also found that VTA cell bodies retrogradely labeled from the various target brain regions had distinct distribution patterns within the VTA, including in the locations of DA and GABA neurons. Despite this patterned organization, VTA neurons comprising these different projections were intermingled and never limited to any one subregion. These anatomical results are consistent with the idea that VTA neurons participate in multiple distinct, parallel circuits that differentially contribute to motivation and reward. While attention has largely focused on VTA DA neurons, a better understanding of VTA subpopulations, especially the contribution of non-DA neurons to projections, will be critical for future work. K E Y W O R D S dopamine, GABA, immunocytochemistry, retrograde, RRID: AB_2278725, RRID: AB_390204,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.